CD34 and systemic sclerosis: As the principal finding, we demonstrate for the first time that both the immunohistochemical and ultrastructural abnormalities in TCs/CD34+ stromal cells previously described in lesional skin of SSc patients [31] are faithfully reproduced in the skin of bleomycin-treated mice.